BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 33394687)

  • 21. Dexamethasone inhibits hypoxia-induced epithelial-mesenchymal transition in colon cancer.
    Kim JH; Hwang YJ; Han SH; Lee YE; Kim S; Kim YJ; Cho JH; Kwon KA; Kim JH; Kim SH
    World J Gastroenterol; 2015 Sep; 21(34):9887-99. PubMed ID: 26379394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoxic induction of vasculogenic mimicry in hepatocellular carcinoma: role of HIF-1 α, RhoA/ROCK and Rac1/PAK signaling.
    Zhang JG; Zhou HM; Zhang X; Mu W; Hu JN; Liu GL; Li Q
    BMC Cancer; 2020 Jan; 20(1):32. PubMed ID: 31931758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evodiamine exerts anti-tumor effects against hepatocellular carcinoma through inhibiting β-catenin-mediated angiogenesis.
    Shi L; Yang F; Luo F; Liu Y; Zhang F; Zou M; Liu Q
    Tumour Biol; 2016 Sep; 37(9):12791-12803. PubMed ID: 27449032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-148a inhibits early relapsed colorectal cancers and the secretion of VEGF by indirectly targeting HIF-1α under non-hypoxia/hypoxia conditions.
    Tsai HL; Miao ZF; Chen YT; Huang CW; Yeh YS; Yang IP; Wang JY
    J Cell Mol Med; 2019 May; 23(5):3572-3582. PubMed ID: 30834693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combretastatin A4 phosphate treatment induces vasculogenic mimicry formation of W256 breast carcinoma tumor in vitro and in vivo.
    Yao N; Ren K; Jiang C; Gao M; Huang D; Lu X; Lou B; Peng F; Yang A; Wang X; Ni Y; Zhang J
    Tumour Biol; 2015 Nov; 36(11):8499-510. PubMed ID: 26026583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of hCG in vasculogenic mimicry in OVCAR-3 ovarian cancer cell line.
    Su M; Wei W; Xu X; Wang X; Chen C; Su L; Zhang Y
    Int J Gynecol Cancer; 2011 Nov; 21(8):1366-74. PubMed ID: 22027746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triptonide potently suppresses pancreatic cancer cell-mediated vasculogenic mimicry by inhibiting expression of VE-cadherin and chemokine ligand 2 genes.
    Han H; Du L; Cao Z; Zhang B; Zhou Q
    Eur J Pharmacol; 2018 Jan; 818():593-603. PubMed ID: 29162433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microbial metabolite deoxycholic acid promotes vasculogenic mimicry formation in intestinal carcinogenesis.
    Song X; An Y; Chen D; Zhang W; Wu X; Li C; Wang S; Dong W; Wang B; Liu T; Zhong W; Sun T; Cao H
    Cancer Sci; 2022 Feb; 113(2):459-477. PubMed ID: 34811848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peroxiredoxin 2 is involved in vasculogenic mimicry formation by targeting VEGFR2 activation in colorectal cancer.
    Zhang S; Fu Z; Wei J; Guo J; Liu M; Du K
    Med Oncol; 2015 Jan; 32(1):414. PubMed ID: 25471788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imperatorin suppresses proliferation and angiogenesis of human colon cancer cell by targeting HIF-1α via the mTOR/p70S6K/4E-BP1 and MAPK pathways.
    Mi C; Ma J; Wang KS; Zuo HX; Wang Z; Li MY; Piao LX; Xu GH; Li X; Quan ZS; Jin X
    J Ethnopharmacol; 2017 May; 203():27-38. PubMed ID: 28341244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphorylation of STAT3 Promotes Vasculogenic Mimicry by Inducing Epithelial-to-Mesenchymal Transition in Colorectal Cancer.
    Han C; Sun B; Zhao X; Zhang Y; Gu Q; Liu F; Zhao N; Wu L
    Technol Cancer Res Treat; 2017 Dec; 16(6):1209-1219. PubMed ID: 29333928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LRG1 modulates epithelial-mesenchymal transition and angiogenesis in colorectal cancer via HIF-1α activation.
    Zhang J; Zhu L; Fang J; Ge Z; Li X
    J Exp Clin Cancer Res; 2016 Feb; 35():29. PubMed ID: 26856989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC; Lee CF; Huang WH; Chou TC
    Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoxia induced epithelial-mesenchymal transition and vasculogenic mimicry formation by promoting Bcl-2/Twist1 cooperation.
    Liu K; Sun B; Zhao X; Wang X; Li Y; Qiu Z; Gu Q; Dong X; Zhang Y; Wang Y; Zhao N
    Exp Mol Pathol; 2015 Oct; 99(2):383-91. PubMed ID: 26318343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of interleukin-17F on vasculogenic mimicry in oral tongue squamous cell carcinoma.
    Almahmoudi R; Salem A; Hadler-Olsen E; Svineng G; Salo T; Al-Samadi A
    Cancer Sci; 2021 Jun; 112(6):2223-2232. PubMed ID: 33743555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
    Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
    J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigallocatechin-3-Gallate Suppresses Vasculogenic Mimicry through Inhibiting the Twist/VE-Cadherin/AKT Pathway in Human Prostate Cancer PC-3 Cells.
    Yeo C; Han DS; Lee HJ; Lee EO
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COE inhibits vasculogenic mimicry in hepatocellular carcinoma via suppressing Notch1 signaling.
    Jue C; Min Z; Zhisheng Z; Lin C; Yayun Q; Xuanyi W; Feng J; Haibo W; Youyang S; Tadashi H; Shintaro I; Shiyu G; Yanqing L
    J Ethnopharmacol; 2017 Aug; 208():165-173. PubMed ID: 28694103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer.
    Sui H; Zhao J; Zhou L; Wen H; Deng W; Li C; Ji Q; Liu X; Feng Y; Chai N; Zhang Q; Cai J; Li Q
    Cancer Lett; 2017 Sep; 403():86-97. PubMed ID: 28602978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiogenesis and vasculogenic mimicry are inhibited by 8-Br-cAMP through activation of the cAMP/PKA pathway in colorectal cancer.
    Wang S; Zhang Z; Qian W; Ji D; Wang Q; Ji B; Zhang Y; Zhang C; Sun Y; Zhu C; Sun Y
    Onco Targets Ther; 2018; 11():3765-3774. PubMed ID: 29997437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.